Moderna and Pfizer Confirm Use of mRNA Technology for Gene Therapy
1 report, 1 independent
Updated Oct 5
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Moderna and Pfizer confirmed their use of mRNA technology for gene therapy applications on October 5, 2026. An independent report cited a former Pfizer toxicologist, Helmut Sturz, who alleged that the mRNA platform is gene therapy and a biological weapon.
From naturalnews.com
Why it matters
The confirmation of mRNA use in gene therapy is significant for the biopharmaceutical market, where Moderna and Pfizer are direct competitors. The technology is central to the joint development efforts between Moderna and Merck KGaA, and Moderna and Merck.
From naturalnews.com
Who's involved
- ModernaAmerican biotechnology company utilizing mRNA technology for gene therapy
- PfizerAmerican multinational pharmaceutical corporation utilizing mRNA technology for gene therapy
- Merck KGaAGerman multinational science and technology company partnering with Moderna on mRNA cancer vaccines
- MerckPublic company in Indonesia collaborating with Moderna on personalized mRNA cancer vaccines
Keep exploring
The entities involved
-
Moderna
American biotechnology company
-
Pfizer
American multinational pharmaceutical and biotechnology corporation
Related events
- Sweden has abolished the use of mRNA products manufactured by both Pfizer and Moderna.
- Moderna and Merck announced a partnership on their mRNA cancer vaccine trial, leading to analyst rating hikes.
- Moderna, Pfizer, and Merck are part of a healthcare rotation story, with Moderna outperforming Pfizer in current stock gains.
- Moderna and Iovance Biotherapeutics, alongside Dell, SanDisk, and MaxLinear, were noted among top stock gainers.
- Moderna and Merck are seeking FDA review for a novel cancer treatment, having co-led a Phase 3 mRNA vaccine trial.